Jerome J. Lande - Jun 1, 2023 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Daniel S. Jonas for Jerome J. Lande by Power of Attorney
Stock symbol
CNMD
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/2/2023, 05:40 PM
Previous filing
Apr 5, 2023
Next filing
Jul 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +335 +10.41% $0.00 3.55K Jun 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -335 -100% $0.00* 0 Jun 1, 2023 Common Stock 335 $0.00 Direct F1
transaction CNMD Rsus (restricted Stock Units) Award $0 +302 $0.00 302 Jun 1, 2023 Common Stock 302 $0.00 Direct F1
transaction CNMD Options To Purchase Common Stock Award $0 +2.83K $0.00 2.83K Jun 1, 2023 Common Stock 2.83K $123.79 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.